INOVIQ Ltd (ASX:IIQ)
Australia · Delayed Price · Currency is AUD
0.3850
+0.0400 (11.59%)
Feb 26, 2026, 3:56 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Research and Development of Cancer Diagnostics | 1.82M | 1.56M | 1.55M | 2.00M | 1.27M | | | | | |
Research and Development of Cancer Diagnostics Growth | 16.25% | 0.67% | -22.33% | 57.16% | 137.48% | | | | | |
| 1.82M | 1.56M | 1.55M | 2.00M | 1.27M | | | | | |
| 16.25% | 0.67% | -22.33% | 57.16% | 137.48% | | | | | |
Source: S&P Global Market Intelligence.